Back

Latest Forum Topics / QT Vascular

Post Reply

QTV - potential to go back to 50cts? Post Reply Rate topic
tankookoo Master	31-May-2017 18:16        tankookoo About Contact  Quote this Post!
x 0   x 0  Alert Admin	Looks like something brewing..else QT should have responsed to SGX that ' not aware' .... hopefully good news and tomorrow surge past 4 cents....4.5.....then to ...5....6....7.....8.....9... huat AR!! ProRobot      ( Date: 31-May-2017 16:08) Posted: Why does it take QT so long to response to SGX query on abnormal trading activity and why do QT want to extend the AGM meeting to a later date which was rejected by ACRA? Is there something fishy going on?
Useful To Me  Not Useful To Me
jeremyow Master	31-May-2017 16:48        jeremyow About Contact  Quote this Post! Style: Flexible   Mood: Yells: "Passionate business investor"
x 0   x 0  Alert Admin	Thanks Stanton for your inputs! It certainly help to have different perspectives to a company. What you mentioned could be a positive catalyst for QT Vascular. That is why in businesses and of course for us investors in assessing the business in question, the future could be any possibilities. No one holds a crystal ball in this aspect. What we are trying to do is make good whatever information we know currently about a business and work out our probability on the possible outcome of the business in near term. Anything too far into the future is at best only a fuzzy estimate. On your YuuZoo' s fall in share price comment, I agree with you. And I also think any opportunistic short selling by short sellers like Gem and other short sellers plus genuine selling by investors are both responsible for the fall in share price of course trigerred by the series of negative news surrounding YuuZoo as you have pointed out.  Stanton      ( Date: 31-May-2017 15:41) Posted: To a very large extend, I agree with what you say. I started trading this stock around 20c range and lost quite a lot but recently started to recover back. Between that time and now the stock price slide but they have also further enhanced their product and obtained more regulatory approvals. If entering at current price level, I am less concerned because MNCs have already shown interest in buying their products. If it does fall further, privatization is very possible. Either management buyout or MNC buy them up and takeover their FDA approved products cheaply. Yes GEM could be a factor but it is more of an overhang rather than shorting price down. There is price mechanism that GEM will not sell below certain price. You can read up the agreement on SGX. In Yuuzoo case, the fall in share price is not caused by GEM but their inability to provide audited financial statements and unable to demonstrate a successful business. Essentially I am saying that at current price range the betting risk to me is low and yes, I have invested. jeremyow      ( Date: 31-May-2017 14:22) Posted: http://www.straitstimes.com/business/qt-vascular-gets-10m-lifeline-with-caveats I attach a link from Straits Times (ST) article which discusses how QT Vascular manages to stay afloat while  being a loss making company by  raising cash from various parties including a party Gem Global Yield Fund mentioned in this article. I have also checked up their trend of financials for past few years and also browsed through their 2015 and 2016 annual reports. The auditor of their financial accounts while stating that QT Vascular has put up fairly accurate and sound financial statements with no intention of misrepresentation, expressed the concern whether QT Vascular given their current liabilities is so much more than current assets incurring a negative working capital is able to still continue as an ongoing concern. The current ratio I calculated is 0.21 for their FY2016 financial results. This means current assets is only about 21% of current liabilities. How to meet the obligations to their current liabilites if their current assets is only 21% of current liabilites?  In addition, looking at the breakdown of the individual items, inventories, trade and other receivables, and cash and cash equivalents, all have decreased in 2016 as compared to 2015. Lesser inventories, lesser trade and other receivables, and lesser cash and cash equivalents for 2016 over 2015. The current assets has thus decreased by around 53% from 2015 to 2016. This is such a significant decrease in current assets. Looks like the company is either downsizing in their businesses or they just simply cannot keep up their businesses anymore with such a huge drop in value of current assets with every items listed in the current assets also decreasing by good amount.  To make matters worse, the company has an amount of accumlated losses carried on its balance sheet which is currently more than amount of share capital. This shows the company has lost an amount of money which has surpassed the amount it has raised thus far from issuance of its shares. In simple sense, it means that for every 1 dollar put in by an investor, one would have already lost the entire 1 dollar plus incurred even more losses than original $1. Of course, when a company goes bankrupt, an investor will not be liable to pay any liabilities of a company, so there is no worry about such thing even as the company has accumulated losses more than the amount of share capital. But, due to the accumulated losses already more than the share capital, this does mean that even if the company should start making progress in becoming profitable, it may take a very long time to see every $1 an investor has put in break even eventually, not to even talk about making money.           As such, QT Vascular carries a negative equity on its balance sheet due to the huge amount of accumulated losses. The net asset value per share (NAV per share) is thus also negative.  The management of QT Vascular in response to their auditor' s concern based on their consolidated financial statements to continue as an ongoing concern, mentioned that there is no cause for concern as the company has avenues to tap into capital sources from various parties. Yes, no doubt the company can continue to invent ways to raise funds to keep the company going. But, the various methods of fund raising maybe disadvantageous for the shareholders.  For example, the recent raising of funds from Gem  Global Yield Fund by manner of issuing new shares to Gem will surely have a dilutive effect on the share-ownership of shareholders. Also, Gem is able to borrow shares from QT Vascular under the same agreement before Gem is issued with shares from the fund raising by QT Vascular and this may result in volatility in the share price if Gem trades QT Vascular shares to capitalise on any price differences.  In the ST article, it was mentioned that Gem also did a deal similar in nature with YuuZoo Corp by borrowing shares of YuuZoo prior to being issued shares with a 10% price difference. This allowed Gem to short YuuZoo shares to make short-selling profits and thus YuuZoo share price has fallen since then.  There is indeed a strong caveat if one is considering investing in QT Vascular purely on fundamentals as there is simply many hidden worms in the can. Even if one is trading the shares of QT Vascular on a short term basis, it can be very volatile in view of big boys like Gem which also trades the shares for their interest. Of course, there is always the hope that QT Vascular can unlock the value in its intanglible assets which may prove to be very profitable to them and also their shareholders. But, they had better do this fast or else at the rate that they are sinking in their businesses with accumulated losses and cash burn, they may incur substantial liabilities they have to account to eventually from any further debts and equity they issued, so much so that any value unlocked through asset sales may not be as profitable anymore on an abnormally enlarged share base and debts to pay.
Useful To Me  Not Useful To Me
ProRobot Member	31-May-2017 16:08        ProRobot About Contact  Quote this Post!
x 0   x 0  Alert Admin	Why does it take QT so long to response to SGX query on abnormal trading activity and why do QT want to extend the AGM meeting to a later date which was rejected by ACRA? Is there something fishy going on?
Useful To Me  Not Useful To Me
Stanton Veteran	31-May-2017 15:41        Stanton About Contact  Quote this Post!
x 0   x 0  Alert Admin	To a very large extend, I agree with what you say. I started trading this stock around 20c range and lost quite a lot but recently started to recover back. Between that time and now the stock price slide but they have also further enhanced their product and obtained more regulatory approvals. If entering at current price level, I am less concerned because MNCs have already shown interest in buying their products. If it does fall further, privatization is very possible. Either management buyout or MNC buy them up and takeover their FDA approved products cheaply. Yes GEM could be a factor but it is more of an overhang rather than shorting price down. There is price mechanism that GEM will not sell below certain price. You can read up the agreement on SGX. In Yuuzoo case, the fall in share price is not caused by GEM but their inability to provide audited financial statements and unable to demonstrate a successful business. Essentially I am saying that at current price range the betting risk to me is low and yes, I have invested. jeremyow      ( Date: 31-May-2017 14:22) Posted: http://www.straitstimes.com/business/qt-vascular-gets-10m-lifeline-with-caveats I attach a link from Straits Times (ST) article which discusses how QT Vascular manages to stay afloat while  being a loss making company by  raising cash from various parties including a party Gem Global Yield Fund mentioned in this article. I have also checked up their trend of financials for past few years and also browsed through their 2015 and 2016 annual reports. The auditor of their financial accounts while stating that QT Vascular has put up fairly accurate and sound financial statements with no intention of misrepresentation, expressed the concern whether QT Vascular given their current liabilities is so much more than current assets incurring a negative working capital is able to still continue as an ongoing concern. The current ratio I calculated is 0.21 for their FY2016 financial results. This means current assets is only about 21% of current liabilities. How to meet the obligations to their current liabilites if their current assets is only 21% of current liabilites?  In addition, looking at the breakdown of the individual items, inventories, trade and other receivables, and cash and cash equivalents, all have decreased in 2016 as compared to 2015. Lesser inventories, lesser trade and other receivables, and lesser cash and cash equivalents for 2016 over 2015. The current assets has thus decreased by around 53% from 2015 to 2016. This is such a significant decrease in current assets. Looks like the company is either downsizing in their businesses or they just simply cannot keep up their businesses anymore with such a huge drop in value of current assets with every items listed in the current assets also decreasing by good amount.  To make matters worse, the company has an amount of accumlated losses carried on its balance sheet which is currently more than amount of share capital. This shows the company has lost an amount of money which has surpassed the amount it has raised thus far from issuance of its shares. In simple sense, it means that for every 1 dollar put in by an investor, one would have already lost the entire 1 dollar plus incurred even more losses than original $1. Of course, when a company goes bankrupt, an investor will not be liable to pay any liabilities of a company, so there is no worry about such thing even as the company has accumulated losses more than the amount of share capital. But, due to the accumulated losses already more than the share capital, this does mean that even if the company should start making progress in becoming profitable, it may take a very long time to see every $1 an investor has put in break even eventually, not to even talk about making money.           As such, QT Vascular carries a negative equity on its balance sheet due to the huge amount of accumulated losses. The net asset value per share (NAV per share) is thus also negative.  The management of QT Vascular in response to their auditor' s concern based on their consolidated financial statements to continue as an ongoing concern, mentioned that there is no cause for concern as the company has avenues to tap into capital sources from various parties. Yes, no doubt the company can continue to invent ways to raise funds to keep the company going. But, the various methods of fund raising maybe disadvantageous for the shareholders.  For example, the recent raising of funds from Gem  Global Yield Fund by manner of issuing new shares to Gem will surely have a dilutive effect on the share-ownership of shareholders. Also, Gem is able to borrow shares from QT Vascular under the same agreement before Gem is issued with shares from the fund raising by QT Vascular and this may result in volatility in the share price if Gem trades QT Vascular shares to capitalise on any price differences.  In the ST article, it was mentioned that Gem also did a deal similar in nature with YuuZoo Corp by borrowing shares of YuuZoo prior to being issued shares with a 10% price difference. This allowed Gem to short YuuZoo shares to make short-selling profits and thus YuuZoo share price has fallen since then.  There is indeed a strong caveat if one is considering investing in QT Vascular purely on fundamentals as there is simply many hidden worms in the can. Even if one is trading the shares of QT Vascular on a short term basis, it can be very volatile in view of big boys like Gem which also trades the shares for their interest. Of course, there is always the hope that QT Vascular can unlock the value in its intanglible assets which may prove to be very profitable to them and also their shareholders. But, they had better do this fast or else at the rate that they are sinking in their businesses with accumulated losses and cash burn, they may incur substantial liabilities they have to account to eventually from any further debts and equity they issued, so much so that any value unlocked through asset sales may not be as profitable anymore on an abnormally enlarged share base and debts to pay.    tankookoo      ( Date: 31-May-2017 12:22) Posted: what is the worth of the company, it seems to have negative equity..
Useful To Me  Not Useful To Me
NextEvolution Elite	31-May-2017 15:31        NextEvolution About Contact  Quote this Post!
x 0   x 0  Alert Admin	sh0rthere, still holding this baby? Mine is quick deal. Entered yesterday at 3.1 & 3.2 liquidated all earlier NextEvolution      ( Date: 31-May-2017 15:02) Posted: Didn't short lah. Just took nice profit earlier , not at the high 4 but very good price to me. Enjoy your ride Bro sh0rthere      ( Date: 31-May-2017 12:39) Posted: Go short it then. I am waiting for you to cover abv 40. Lol
Useful To Me  Not Useful To Me
NextEvolution Elite	31-May-2017 15:02        NextEvolution About Contact  Quote this Post!
x 0   x 0  Alert Admin	Didn't short lah. Just took nice profit earlier , not at the high 4 but very good price to me. Enjoy your ride Bro sh0rthere      ( Date: 31-May-2017 12:39) Posted: Go short it then. I am waiting for you to cover abv 40. Lol. NextEvolution      ( Date: 31-May-2017 12:05) Posted: 3.8 like heavy distribution. Either it will break thru to above 4 or drop back down to 3.5 to 3.6 range these few days. Algorithm buying selling no more detected since morning trade
Useful To Me  Not Useful To Me
jeremyow Master	31-May-2017 14:22        jeremyow About Contact  Quote this Post! Style: Flexible   Mood: Yells: "Passionate business investor"
x 0   x 0  Alert Admin	http://www.straitstimes.com/business/qt-vascular-gets-10m-lifeline-with-caveats I attach a link from Straits Times (ST) article which discusses how QT Vascular manages to stay afloat while  being a loss making company by  raising cash from various parties including a party Gem Global Yield Fund mentioned in this article. I have also checked up their trend of financials for past few years and also browsed through their 2015 and 2016 annual reports. The auditor of their financial accounts while stating that QT Vascular has put up fairly accurate and sound financial statements with no intention of misrepresentation, expressed the concern whether QT Vascular given their current liabilities is so much more than current assets incurring a negative working capital is able to still continue as an ongoing concern. The current ratio I calculated is 0.21 for their FY2016 financial results. This means current assets is only about 21% of current liabilities. How to meet the obligations to their current liabilites if their current assets is only 21% of current liabilites?  In addition, looking at the breakdown of the individual items, inventories, trade and other receivables, and cash and cash equivalents, all have decreased in 2016 as compared to 2015. Lesser inventories, lesser trade and other receivables, and lesser cash and cash equivalents for 2016 over 2015. The current assets has thus decreased by around 53% from 2015 to 2016. This is such a significant decrease in current assets. Looks like the company is either downsizing in their businesses or they just simply cannot keep up their businesses anymore with such a huge drop in value of current assets with every items listed in the current assets also decreasing by good amount.  To make matters worse, the company has an amount of accumlated losses carried on its balance sheet which is currently more than amount of share capital. This shows the company has lost an amount of money which has surpassed the amount it has raised thus far from issuance of its shares. In simple sense, it means that for every 1 dollar put in by an investor, one would have already lost the entire 1 dollar plus incurred even more losses than original $1. Of course, when a company goes bankrupt, an investor will not be liable to pay any liabilities of a company, so there is no worry about such thing even as the company has accumulated losses more than the amount of share capital. But, due to the accumulated losses already more than the share capital, this does mean that even if the company should start making progress in becoming profitable, it may take a very long time to see every $1 an investor has put in break even eventually, not to even talk about making money.           As such, QT Vascular carries a negative equity on its balance sheet due to the huge amount of accumulated losses. The net asset value per share (NAV per share) is thus also negative.  The management of QT Vascular in response to their auditor' s concern based on their consolidated financial statements to continue as an ongoing concern, mentioned that there is no cause for concern as the company has avenues to tap into capital sources from various parties. Yes, no doubt the company can continue to invent ways to raise funds to keep the company going. But, the various methods of fund raising maybe disadvantageous for the shareholders.  For example, the recent raising of funds from Gem  Global Yield Fund by manner of issuing new shares to Gem will surely have a dilutive effect on the share-ownership of shareholders. Also, Gem is able to borrow shares from QT Vascular under the same agreement before Gem is issued with shares from the fund raising by QT Vascular and this may result in volatility in the share price if Gem trades QT Vascular shares to capitalise on any price differences.  In the ST article, it was mentioned that Gem also did a deal similar in nature with YuuZoo Corp by borrowing shares of YuuZoo prior to being issued shares with a 10% price difference. This allowed Gem to short YuuZoo shares to make short-selling profits and thus YuuZoo share price has fallen since then.  There is indeed a strong caveat if one is considering investing in QT Vascular purely on fundamentals as there is simply many hidden worms in the can. Even if one is trading the shares of QT Vascular on a short term basis, it can be very volatile in view of big boys like Gem which also trades the shares for their interest. Of course, there is always the hope that QT Vascular can unlock the value in its intanglible assets which may prove to be very profitable to them and also their shareholders. But, they had better do this fast or else at the rate that they are sinking in their businesses with accumulated losses and cash burn, they may incur substantial liabilities they have to account to eventually from any further debts and equity they issued, so much so that any value unlocked through asset sales may not be as profitable anymore on an abnormally enlarged share base and debts to pay.    tankookoo      ( Date: 31-May-2017 12:22) Posted: what is the worth of the company, it seems to have negative equity..   Maller      ( Date: 31-May-2017 12:16) Posted: I am very confident as they are able to realize good value to their assets and EDB still invested.   dyodd
Useful To Me  Not Useful To Me
Demostation Supreme	31-May-2017 13:00        Demostation About Contact  Quote this Post!
x 0   x 0  Alert Admin	There is plenty of goodwill that usually come with FDA' s approvals.   So think this one can be potential. tankookoo      ( Date: 31-May-2017 12:22) Posted: what is the worth of the company, it seems to have negative equity..   Maller      ( Date: 31-May-2017 12:16) Posted: I am very confident as they are able to realize good value to their assets and EDB still invested.   dyodd
Useful To Me  Not Useful To Me
Stanton Veteran	31-May-2017 12:58        Stanton About Contact  Quote this Post!
x 0   x 0  Alert Admin	You won't find the value of QTV in the balance sheet. It is in the market value of its products, research, patents, FDA approvals. These are intangible and there are big medical companies out there interested to buy over QTV's products. The Medtronic deal if done is worth US$28 million close to QTV market cap. They have also announced that they are in the process of discussing with serval interested parties on other products. This is where the value is. tankookoo      ( Date: 31-May-2017 12:22) Posted: what is the worth of the company, it seems to have negative equity..   Maller      ( Date: 31-May-2017 12:16) Posted: I am very confident as they are able to realize good value to their assets and EDB still invested.   dyodd
Useful To Me  Not Useful To Me
Demostation Supreme	31-May-2017 12:44        Demostation About Contact  Quote this Post!
x 0   x 0  Alert Admin	Aiya, my mistake.   Friday is the EGM. 2/06/2017 8.00 am.   Go and ask questions on the future of the company.   Lol. Demostation      ( Date: 31-May-2017 12:42) Posted: Lets attend   this Wednesday' s EGM.   It has some interesting resolutions to pass.   This morning agm went on as per normal as you would expect in an AGM.   Reappointment of directors, remunerations, auditors and some simple questions and answers.   Did not get much out of it.   So maybe this coming EGM should attend and ask some important questions. tankookoo      ( Date: 31-May-2017 12:22) Posted: what is the worth of the company, it seems to have negative equity..
Useful To Me  Not Useful To Me
Demostation Supreme	31-May-2017 12:42        Demostation About Contact  Quote this Post!
x 0   x 0  Alert Admin	Lets attend   this Wednesday' s EGM.   It has some interesting resolutions to pass.   This morning agm went on as per normal as you would expect in an AGM.   Reappointment of directors, remunerations, auditors and some simple questions and answers.   Did not get much out of it.   So maybe this coming EGM should attend and ask some important questions. tankookoo      ( Date: 31-May-2017 12:22) Posted: what is the worth of the company, it seems to have negative equity..   Maller      ( Date: 31-May-2017 12:16) Posted: I am very confident as they are able to realize good value to their assets and EDB still invested.   dyodd
Useful To Me  Not Useful To Me
sh0rthere Senior	31-May-2017 12:39        sh0rthere About Contact  Quote this Post!
x 0   x 0  Alert Admin	Go short it then. I am waiting for you to cover abv 40. Lol. NextEvolution      ( Date: 31-May-2017 12:05) Posted: 3.8 like heavy distribution. Either it will break thru to above 4 or drop back down to 3.5 to 3.6 range these few days. Algorithm buying selling no more detected since morning trades NextEvolution      ( Date: 31-May-2017 09:09) Posted: Computer algorithm trading this QTV today. Interesting to see how it head this week. Waited for weeks with little movement after all the good news
Useful To Me  Not Useful To Me
tankookoo Master	31-May-2017 12:22        tankookoo About Contact  Quote this Post!
x 0   x 0  Alert Admin	what is the worth of the company, it seems to have negative equity..   Maller      ( Date: 31-May-2017 12:16) Posted: I am very confident as they are able to realize good value to their assets and EDB still invested.   dyodd
Useful To Me  Not Useful To Me
Maller Elite	31-May-2017 12:16        Maller About Contact  Quote this Post!
x 0   x 0  Alert Admin	I am very confident as they are able to realize good value to their assets and EDB still invested.   dyodd
Useful To Me  Not Useful To Me
NextEvolution Elite	31-May-2017 12:05        NextEvolution About Contact  Quote this Post!
x 0   x 0  Alert Admin	3.8 like heavy distribution. Either it will break thru to above 4 or drop back down to 3.5 to 3.6 range these few days. Algorithm buying selling no more detected since morning trades NextEvolution      ( Date: 31-May-2017 09:09) Posted: Computer algorithm trading this QTV today. Interesting to see how it head this week. Waited for weeks with little movement after all the good news
Useful To Me  Not Useful To Me
sengsk Elite	31-May-2017 11:00        sengsk About Contact  Quote this Post!
x 0   x 0  Alert Admin	Agreed ! Fibo range ~ 50 to 61.8% Demostation      ( Date: 31-May-2017 10:31) Posted: After EGM regarding Medtronics, we might see above 4 to 5.   Just dyodd. Stanton      ( Date: 31-May-2017 10:06) Posted: Breakout with high volume after agm. Friday got egm on Medtronic option. Hope CEO will bring positive news.
Useful To Me  Not Useful To Me
Demostation Supreme	31-May-2017 10:31        Demostation About Contact  Quote this Post!
x 0   x 0  Alert Admin	After EGM regarding Medtronics, we might see above 4 to 5.   Just dyodd. Stanton      ( Date: 31-May-2017 10:06) Posted: Breakout with high volume after agm. Friday got egm on Medtronic option. Hope CEO will bring positive news. bank123      ( Date: 31-May-2017 10:03) Posted: All charts show strong break up with high volume, bullish signs. 4 cents coming soon.
Useful To Me  Not Useful To Me
Demostation Supreme	31-May-2017 10:24        Demostation About Contact  Quote this Post!
x 0   x 0  Alert Admin	Looks like good future.   Maybe you are right, it is good for its value. Stanton      ( Date: 30-May-2017 19:06) Posted: Thanks and yes, this is either make or break co. But Inhave a good feeling they will succeed. Anyway at 3c my risk is low compare to sotong who bet on the zoo that has nothing but virtual assets. Demostation      ( Date: 30-May-2017 17:09) Posted: Will try my best to attend.   This company meeting must go because very high chance of success and failure,.   To protect your investment, better try your best to go.   But if you cannot make it, never mind, I will post any news here.
Useful To Me  Not Useful To Me
Stanton Veteran	31-May-2017 10:06        Stanton About Contact  Quote this Post!
x 0   x 0  Alert Admin	Breakout with high volume after agm. Friday got egm on Medtronic option. Hope CEO will bring positive news. bank123      ( Date: 31-May-2017 10:03) Posted: All charts show strong break up with high volume, bullish signs. 4 cents coming soon.
Useful To Me  Not Useful To Me
Maller Elite	31-May-2017 10:05        Maller About Contact  Quote this Post!
x 0   x 0  Alert Admin	The recent sales prove that their assets have much value and they could focus on the strategic products now...edb still holding...dyodd
Useful To Me  Not Useful To Me

                                                         First   < Newer   5441-5460 of 6236   Older>   Last